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Introduction
Fragment based drug discovery (FBDD) is frequently used to identify small organic molecules (fragments) as starting points for further structure-based drug design (SBDD) programs that aim to deliver drug-like molecules suitable for clinical studies. Fragments can be described using the "rule of 3" [1] [2, 3] . According to this rule, a fragment is typically an organic molecule with molecular weight (Mw) ≤ 300 Da, number of H-bond acceptors ≤ 3, number of H-bond donors ≤ 3 and clogP (computed partition coefficient) ≤ 3 [1] . Fragments typically exhibit a dissociation constant in the micromolar to low millimolar range and the success of FBDD can be linked to steady improvements in robust biophysical characterisation of weak binding [2, 4] .
A number of problems are associated with the effective screening of fragment libraries. It is often difficult to solubilise fragments at concentrations required to saturate a protein target. Additionally the presence of aggregates, impurities and/or reactive intermediates can also lead to false positives or negatives. These issues are exacerbated for particularly small fragments (≤ 150 Da) that are likely to exhibit at best mM dissociation constants, and there is a need for pushing the limits of detection of weak binding to broaden the scope of FBDD.
The past decade has seen rapid developments in the application of molecular simulations to structure-based drug design [5] . Molecular simulations and free energy calculations are now being used to complement experimental approaches for a wide range of proteinligand complexes, including estimation of binding energies of drug-like molecules [6, 7] , and fragments [8] . This report focuses on the combination of biophysical measurements and molecular simulation methods to characterize weak Cyclophilins (Cyps) binders present within a library of small fragments.
Cyclophilins (Cyps) are a family of peptidyl-prolyl isomerases (PPIases) that catalyze the isomerization of proline residues, promoting and facilitating protein folding [9] . The human cyclophilin family counts seventeen members with the prototype and most abundant being cyclophilin A (CypA) [10] . Cyclophilin orthologues can also be found in most plants, parasites and animals [11, 12] . The amino acid sequences of all human Cyps are well established, as well as their secondary and tertiary structures [10] . All Cyps share a highly conserved PPIase domain. Cyps are also members of the immunophilins class of proteins [13] [14] [15] and many Cyps are inhibited by the natural immunosuppressant cyclosporin A (CsA) [10, 15] . CsA is used in organ transplantation to prevent immune response and organ rejection. Cyps are also involved in (mis)regulation of several biological signaling pathways including damage-induced cell death [16] , RNA splicing [17] and different types of cancer.
Cyps are also known to be involved in the life cycle of different viruses such as Human Immunodeficiency Virus 1 (HIV-1) and Hepatitis C Virus (HCV) [18, 19] .
Because of their diverse biological roles Cyps are recognized as potential biological targets for the treatment of HCV [19] [20] [21] , HIV [22] [23] [24] , cancer [25] [26] [27] and neurodegenerative diseases such as Parkinson's and Alzheimer's [28] [29] [30] . Originally, efforts for the identification of cyclophilin inhibitors were focused on cyclic peptides, analogues of CsA [20, 21, 31, 32] . In recent years a number of small-molecule Cyp inhibitors have been reported in the literature as [33] [34] [35] [36] [37] [38] [39] [40] [41] . A major unsolved challenge is to achieve robust binding affinity and specificity to distinct Cyp isoforms. The difficulty arises from the shallow, solvent-exposed nature of the active site of Cyps. Yet high binding specificity is widely thought to be necessary to produce chemical probes able to elucidate the biological roles of different Cyp isoforms, and to pave the way for next-generation Cyp drugs with reduced side-effects in comparison with CsA analogues.
The present work used Surface Plasmon Resonance, X-ray diffraction and molecular dynamics simulations to screen a focused library of small fragments against the most common Cyp isoforms Cyp A, B and D. This combination of multiple methodologies lead to the characterization of novel Cyp fragments that are suitable starting points for further optimization into more potent and isoform specific lead molecules.
Results

A focussed fragment library to interrogate ligandability of the Abu pocket in
Cyclophilins
The starting point for this focused library design was 2,3-diaminopyridine, for which SPR and X-ray data had been generated previously, demonstrating the stoichiometric binding of this fragment to the Abu pocket of CypA ( Figure 1 ) [42] . Comparative analysis of primary protein sequences has suggested that the Abu pocket in Cyps may be utilised to engineer isoform-selective ligands owing to small variations in amino-acids that line up the edge of the pocket between the common isoforms Cyp A-D. This contrasts with the nearby Pro pocket that is more conserved across the Cyp family. Thus small fragment analogues of 2,3-diaminopyridine were selected to study the chemical diversity that would be tolerated by the Abu pocket. A total of one hundred small fragments, structurally distinct from the ones previously tested, were chosen based on chemical similarity and commercial availability.
Analogues include substituted aromatic rings such as pyridines, pyrazines, pyrimidines, as well as non-aromatic rings. A full list is provided in the supplementary Table 1 . The relatively low average molecular weight (ca. 150 g mol -1 ) of the library members is dictated by the small size of the Abu pocket, hence any binders are expected to exhibit at best high micromolar to low millimolar binding constants.
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in rigorously removing potential refractive index artefacts at the analyte concentrations tested. Thus the outcome of the SPR screen was deemed overall encouraging, but further characterisation of potential binders was pursued via other means.
Free energy calculations estimate fragment binding energies in line with experimental data, and suggest binding pocket preferences
The standard (absolute) binding free energies of 86 of the 100 experimentally tested fragments were estimated by alchemical free energy calculations. [43] The 14 excluded compounds were either carrying out a net charge, or were too structurally dissimilar to other compounds in the library to allow straightforward computation of relative free energies of binding (see methods). The overall objective of the project was to discover new Abu pocket binders, but fragments could in principle bind to either the Abu or Pro pockets. Therefore two sets of calculations were executed with fragments docked in the Abu or Pro pockets respectively. Figure 2 depicts a histogram that summarizes the results of these calculations.
The data shows that there is a clear preference for the fragments to bind to the Abu pocket of Cyp A, with a mean and standard deviation of binding energies of -3.0±0.7 kcal.mol -1 vs -0.7±0.5 kcal.mol -1 for the Pro pocket. This was deemed encouraging and reflective of the strategy used to assemble diverse fragments into a focussed library targeting the Abu pocket. Conversion of the calculated absolute binding free energies into dissociation constants indicate that the range of predicted K d s to the Abu pocket of CypA is between 0.5 -30 mM, whereas for the Pro pocket the range is 30 mM -2 mol L -1 . The computed binding energies preferences for the Abu pocket were in line with the 0.5 -20 mM binding constant range that was estimated from the SPR screen. Altogether the molecular dynamics data was supportive of preferential weak mM binding to the Abu pocket for several fragments in the focussed library.
X-ray crystallography provides evidence of binding for several fragments 7
A total of 40 compounds were selected for further X-ray crystallographic studies on CypA, CypB and CypD. The selection of this subset was guided by a combination of factors including: evidence of binding to a Cyp surface in the preceding SPR screen; computed interactions with the Abu/Pro pockets; desire for producing co-crystal structures of fragments bounds to multiple isoforms; evidence of sufficient solubility; available beam-time.
Unfortunately no crystal structures of fragments in complex with CypB or CypD were obtained. Although well diffracting crystals were obtained for CypB, the crystal packing arrangement blocked access to the active site and soaking experiments were thus not successful. CypD yielded crystals that were too fragile for soaking and data collection.
Over thirty compounds that were soaked into CypA crystals diffracted well.
Refinement of the structural data led to the detection of 10 fragments in complex with CypA.
The chemical structures of all such fragments are given in Table 1 and data collection, refinement and Ramachandran plot statistics for each of the CypA complexes are reported in the supplementary Table 2 . Fragments that were not found in the active site of CypA are listed in the supplementary Table 3 . The majority of the observed compounds bind in the Abu pocket, in line with the expectations from the library design strategy and MD calculations, however some fragments were found to bind to the neighbouring Pro pocket.
The pocket preference appears to be dictated by the nature of H-bond donors and acceptors, and also the hydrophobicity of each ligand.
Ligands with hydrogen bond donors and acceptors such as 3, 5, 56, 89, 97, 98 and 99 bind to the more hydrophilic Abu pocket of CypA. This is in agreement with the MD simulations that predicted a preference for the Abu over the Pro pocket for all 7 fragments (mean preference -2.6±1.0 kcal.mol -1 ). These compounds adopt broadly similar binding poses and interactions with the Abu pocket. Compounds 89, 98 and 99 have a very similar binding pose, and the electron density is well defined ( Supplementary Fig. 2 ). Figure 3 depicts fragment 98 and shows how the 4-amino group forms hydrogen bonds with two water molecules, W1 (violet-purple) and W2 (sky-blue). Both W1 and W2 have B-factors values (ca. 15 Å²) lower than for most other water molecules present in the crystal structure.
This was taken as indication that these two hydration sites are well ordered. By contrast the 3-amino group is H-bonded to two additional mobile water molecules W3 (pink) and W4 (green). These water molecules have higher B-factors values (ca. 30 Å²) and are thus expected to be less ordered. Overall this somewhat unusual cluster of water mediated protein-fragment interactions play a key role for fragment binding to the Abu pocket. W1 forms H-bond interactions with three protein residues; Ala101, Gln111 and Gly109; W2 with Gly74, Ser110 and Gln111; W3 with Glu81, Gly75 and W4 with Thr73.
Additionally a diverse range of small functional groups (halides, amino, methyl) is tolerated at a third position on the aromatic ring. Fragments 3, 5, 56 and 97 also bind in the Abu pocket of CypA and occupy the same position as 89, 98 and 99, though their electron density is less well defined. An unambiguous assignment of their binding poses is not possible and, in light of the molecular dynamics simulation results (see below), the electron density map was interpreted as the result of these ligands adopting multiple poses. Fragment 56 seems to be able to adopt a slightly different orientation in the Abu pocket, with the chloro group of the ring buried in the pocket, whereas the amino group is more water exposed. This alternative pose is stabilised by two other water molecules that interact with the amine and the pyrimidine nitrogen atoms of the fragments and residues Gly63 and Thr73. The structure of all compounds bound to the Abu pocket, as well as their electron density and distances between fragments and protein/water molecules can be seen in Supplementary Fig. 2 . Some fragments were found to also bind out of a pocket in the vicinity of the 80's loop. Figure 4 shows fragment 3 as an example. This second binding site lies between two symmetry related Cyp molecules in the crystal CypA with halogencarbonyl contacts to Asn106 and Glu84 and an aromatic interaction with Trp121 of another CypA molecule. This site was deemed to be a crystallographic artefact and ignored for further studies.
Three of the ten fragments, 16, 60 and 61 were found to bind the Pro pocket of CypA instead of the Abu pocket. This contrasts with the MD simulations that predicted a preference for binding to the Abu pocket (mean preference -1.7±0.7 kcal.mol -1 ). Figure 5 shows that crystallography indicates the three fragments establish H-bond interactions in the Pro pocket with the conserved CypA residues, Arg55, Gln63 and Asn102. In contrast to the Abu pocket binders that all contain one aromatic ring, fragments 16, 60, 61 are made of nonplanar six membered rings. Thus a combination of lack of planarity and increased hydrophobicity seems to bias fragments towards binding to the conserved Pro pocket.
Molecular dynamics simulations suggest that some fragments adopt multiple binding modes and help guide the interpretation of X-ray diffraction measurements
The structures of fragments derived by X-ray crystallographic analyses revealed a conserved binding mode that appears to be adopted by all fragments binding to the Abu pocket ( Fig. 3 ). However for some fragments (e.g. 3, 5, 56 and 97) refinement of the structures was ambiguous and suggested that these fragments may adopt two different binding modes in the Abu pocket. This was investigated further by carrying out a detailed analysis of MD simulations of 3 bound to Cyp A. Since 3 shows a high degree of structural similarity to the other fragments found to the Abu pocket, it is anticipated that the observed interactions are also relevant for the other fragments. Figure 6 shows RMSD distributions of 3 from one X-ray crystallographic pose calculated from the MD simulations. A total of three different clusters are apparent in the distribution. Monitoring of hydrogen bonding distances between ligand/protein donor/acceptor groups also indicates three clusters whose structure and population match the results produced by RMSD analyses ( Supplementary Fig. 3 ). The In all MD trajectories water molecules W1 and W2 are very tightly bound in the Abu pocket and stay in the same orientation for the duration of the simulations. This is in agreement with the X-ray data which showed W1 and W2 present in the Abu pocket in all structures with low B-factors. In contrast to W1 and W2, water molecules W3 and W4 are more mobile, and easily displaced by other water molecules during the MD simulations. This is again in agreement with the X-ray results which showed W3 and W4 to have higher Bfactor values compared to the W1 and W2 crystal water sites.
Overall this detailed analysis increased confidence in the interpretation of electron density maps derived from X-ray crystallography, and ligands 3 and 97 were ultimately refined in two different poses with 50% occupancy each ( Supplementary Figure 2 ).
Discussion and Conclusion
How confidently can weak mM fragment binders be determined?
The combined data from SPR, X-ray crystallography measurements and MD simulations provides solid evidence that several of the fragments from the present in-house bespoke library interact with Cyp surfaces with dissociation constants in the low millimolar range. Figure 9 depicts a Venn diagram demonstrating overlap between 'hits' detected between X-ray analyses and MD simulations in the case of Cyp A. The SPR data was deemed too ambiguous to enable meaningful evaluation of hit rates and is thus not included in Figure 9 . Given the criteria used here for declaring a compound a 'hit', X-ray and MD detected 10 and 33 binders respectively. This corresponds to a hit rate of 25-33% for X-ray 
How can molecular dynamics complement biophysical methods in fragment-based drug discovery?
The binding free energies computed via molecular dynamics simulations were able to reproduce the preference for the binding of the fragments to the Abu pocket instead of the Pro pocket of Cyp A. Additionally the MD binding affinity estimates were in line with the range inferred from SPR analysis. These observations suggest that MD simulations can be used to guide the design of focussed fragment libraries enriched in structures more likely to bind a target pocket with a reasonable binding affinity. This contrasts with the more common strategy that involves assembling a generic library of structurally diverse fragments as a primary screening library.
Nevertheless a significant number of MD 'hits' were not observed via X-ray diffraction experiments. Arguably, reliably rank-ordering compounds by potency is particularly challenging for this dataset since by design the focussed library contains compounds that are structurally similar, and thus can all be reasonably modelled in the Abu pocket. Most of the library compounds show a computed standard binding energy that falls within the interval of -3 ± 1 kcal mol -1 (Figure 2 ). The relatively small dynamic range of calculated binding energies poses challenges given the precision of the free energy estimates (ca. 0.4 kcal mol -1 ), and the typical accuracy of classical biomolecular force-fields (typical systematic errors around 1 kcal mol -1 in favourable cases). It is likely that greater performance may be observed for the scoring of structurally diverse fragment libraries. This hypothesis could be tested by blinded-predictions, in a fashion similar to competitions for blinded estimations of standard binding energies of host/guest and protein/drug-like complexes have been organised recently. [44, 45] It also cannot be ruled out that the conditions used to solve protein structures in X-ray crystallography experiments disfavour the binding of some of the fragments predicted by MD simulations to bind in solution.
Analysis and visualisation of MD trajectories for selected fragments proved to be a rich source of structural insights. The simulations revealed that several fragments remained highly dynamic when bound to the Abu pocket. In the case of compound 3, three different poses were characterised in details (Fig .7, Fig .8, Supplementary Fig. 3 and Supplementary   Fig. 4 ). This may explain why the electron density maps of a number of fragments (e.g. 3, 5 13 and 56) were ambiguous and could not be fitted to a single binding pose. This suggests that it may be valuable to carry out MD simulations to assist model refinement process of X-ray diffracted crystals. The additional binding modes inferred from MD may also generate ideas for growing fragments out of the Abu pocket that may have been overlooked if design considerations had relied on a X-ray diffracted crystal structure showing a single pose. For instance the binding poses B and C of compound 3 suggest that Gly72 and Thr73 residues can form additional H-bonds interactions with Cyp binders.
What did the fragments reveal about Cyclophilin inhibition strategies?
The binding modes of the various fragments to the Abu pocket of Cyp A were found to be remarkably similar to the interactions of compounds recently reported by the Pawlotsky and Guichou groups [38, 46] . In these studies, several compounds were described as Cyp [38, 46] . The X-ray structure of one inhibitor (PDB ID 4ZSC) was aligned with 3 from the present study ( Supplementary Fig. 5 ). The fragment aligns well with the ligand and forms similar patterns of interactions (even though the isoforms differ). Finally, the three Cyp A Pro pocket fragments 16, 60 and 61 (Fig .5 ) were found to form interactions similar to those observed in crystal structures of Cyclosporine A in complex with Cyp A [10] . Specifically these three fragments are able to establish H-bond interactions with key structural and catalytic active site residues including Arg55, Gln63 and Asn102.
Considerable efforts have been invested by
Materials and Methods
Protein expression purification and characterization
N-terminal hexa-histidine tagged human Cyclophilin (CypA, CypB and wt CypD) were provided by the Edinburgh Protein Production Facility (EPPF), University of Edinburgh. K133I-CypD plasmid was provided by Dr Jacqueline Dornan (Walkinshaw group, Edinburgh). Expression and purification for all isoforms was performed as described [42] . 
Crystallization and data collection
Purified and his-tag cleaved CypA was concentrated to 30.4 mg ml -1 in PBS buffer.
The vapor diffusion by hanging drop method at 6 ºC was used for the crystallization of CypA. 
Structure determination and refinement
All structures were originally processed with DIMPLE [49] . DIMPLE was followed by multiple cycles of restrained refinement using REFMAC 9 [50, 51] . The side chains of the models were manually adjusted, while ligands and water molecules were added where appropriate using Coot 10 [52] . Further iterative cycles of restrained refinements and manual adjustments of ligands, side chains and water molecules, were carried out until the overall quality of the electron density maps could no longer be further improved.
Preparation of proteins and ligands for free energy calculations
CypA, CypB and CypD structures were taken from the X-ray crystal structures with PDB IDs: 1CWA, 3ICH and 2BIT respectively. All water molecules were removed from the structures except the three tightly bound water molecules in the Abu pocket of cyclophilins [53] . All proteins were capped at the C-terminal and N-terminal with an N-methyl and acetyl groups, respectively. Protonation of the histidine residues was predicted by PROPKA, as implemented in Maestro Protein Preparation Wizard [54, 55] . Specifically, the protonation states of CypA's histidines were: HIE54, HIE70, HID92, HID126; in CypB: HIE54, HID92, HID126 and in CypD: HIE54, HIE70, HID92, HID126 and HID131. Ligands were prepared using Maestro as distributed by Schrödinger package [54] . Most ligands were neutral, but a number were expected to be charged in assay conditions. Since correcting for net-charge changes is non-trivial in free energy calculations, these compounds were not included in the dataset for free energy calculations. [56, 57] 
Docking calculations
All ligands were docked into the Abu and Pro pockets of CypA, CypB and CypD using the Autodock Vina plugin of Pymol [58, 59] . For the docking calculations in the Abu pocket, the grid was centered in the protein's Abu pocket. The box size of the grid was set at x = y = z = 13.12 Å and the spacing between the grid points (x = y = z = 35) was 0.375 Å.
The whole protein was used as a receptor and only one pose was generated for each ligand.
Moreover, three water molecules that are tightly bound in Abu pocket [53] were kept and treated as part of the protein for docking purposes.
All ligands were docked in the Pro pocket of CypA, CypB and CypD, in a similar way.
The grid was centered in the Pro pocket of the protein while the box size of the grid was set at x = y = z = 7.50 Å and the spacing between the grid points (x = y = z = 20) was 0.375 Å.
As was previously described, the whole protein was used as a receptor and only one pose was generated for each ligand.
Free energy calculations set up
The strategy used here consisted in using series of relative free energy calculations to connect all compounds in the dataset to a reference compound, and then to compute a standard (absolute) binding free energy calculation for the reference compound. This twostep procedure yields standard binding free energies for all compounds in the dataset.
For the calculation of relative binding free energies, ligands should be perturbed from one ligand to another in complex with the protein and alone in a water box. For this reason, a perturbation map was generated ( Supplementary Fig. 6 ), by manually connecting all the ligands via multiple transformations. Ligand 3 was set as the center of the map, due to its high chemical similarity to the rest of the compounds. All ligands were connected by keeping the number of perturbation steps to 3 to less than four. Mappings featured compounds with high structural similarity, in order to reduce the number of perturbed atoms in each relative free energy calculation. Input files for all subsequent free energy simulations were set up using FESetup1.1 software [60] .
Protein parametrization was done using the Amber ff14SB force field [61] , while ligands were parametrized using GAFF force field as implemented in amber14 [62, 63] that uses AM1-BCC charges [64, 65] . All systems were solubilized in a rectangular box of TIP3P water molecules, with a box length of 10 Å away from the edge of the solute, and Na + or Clions were added to neutralize the net charge of the system. The systems were energy minimized for 200 steps to alleviate any steric clashes, followed by a heating step to 300 K for 200 ps, with harmonic potential restraints on all non-solvent atoms using a 10 kcal mol -1 Å 2 force constant. Systems were then equilibrated by running short (200 ps) MD runs using NVT ensemble with the same restraints as before. Finally, to stabilize the density a final run of 5 ns using an NPT ensemble at 1 atm was performed. The last trajectory snapshot was used as the starting point for the free energy calculations.
Alchemical free energy calculations
Relative free energy changes for transforming a ligand L1 into a ligand L2 (ΔΔG (L1→L2) ) were calculated as the difference in the free energy change of transforming L1 to L2 in a water box (ΔG w(L1→L2) ) and in complex with the protein (ΔG p(L1→L2) ) as shown by equation1:
The MBAR implementation in the software pymbar was used for the calculation of both ΔG w(L1→L2) and ΔG p(L1→L2) free energy changes [66] . Relative binding free energy calculations were only performed once, and statistical errors were propagated from each step, with the final reported error calculated using equation 2
where the terms on the right hand side are the statistical errors associated with ΔG w (L1→L2) and ΔG p(L1→L2) respectively.
Absolute binding free energies were calculated instead with equation 3:
where (L3) is the absolute binding free energy of ligand 3 (L3). and are the free energies of turning off the partial charges of L3 in water and in complex respectively, while and are the free energies of turning off the Lenard Jones parameters of the uncharged ligand. is the free energy cost of releasing the restraints to reach standard state conditions, as explained in ref [67] . This quantity was computed with a custom script. Each absolute binding free energy calculation was repeated in quadruplicate and the reported value is the average of the quadruplicate. The final error reported for the absolute binding free energy was calculated as the standard error of the mean, from the four repeats.
Free energy simulations were performed using the Sire -OpenMM framework [68, 69] steps and then re-equilibrated at the appropriate λ value for 20 ps. The total length of each simulation (at each λ) was 5 ns, and the perturbed energies were saved every 200 fs. The perturbed energies where post-processed using the MBAR estimator [70] . A softcore potential was used in all simulations [71] . The hydrogen mass repartitioning (HMR) technique [72] was used to increase the timestep of the simulation and decrease the time needed to run each simulation. A 4 fs timestep and a repartitioning factor of 4 were used and all bonds were constrained. Simulations were performed in the NPT ensemble, where temperature control was achieved by using the Andersen thermostat, [73] and pressure control was achieved by a Monte Carlo Barostat. Periodic boundary conditions were applied with a 10 Å cut-off for the non-bonded interactions.
In relative binding free energy simulations interatomic flat-bottom distance restraints of 7.5 ± 3.0 Å in the Abu and Pro pockets were applied with a force constant of 5 kcal mol -1 .
One atom of each ligand was selected and restrained to one protein atom in the Abu pocket and two atoms of the protein in the Pro pocket (HID126 and ILE57 CB atoms). In the Abu pocket the distance restraint tolerance was set to 5.5 ± 1.5 Å and in the Pro pocket to 7.5 ± 1.0 Å. The free energy cost of setting up this restraint was corrected by post-processing the simulations to yield a standard free energy of binding.
All input files for the FESetup and somd codes, and a summary of the calculated free energies obtained by post-processing of the generated trajectories can be downloaded from the github repository located at https://github.com/michellab/cypafragmentsfreeenergy.
Accession numbers
Coordinates and structure factors for all ligands binding CypA were deposited in the protein data bank with accession numbers: CypA_lig3 (5NOQ), CypA_lig5 (5NOR), CypA_lig16
(5NOS), CypA_lig56 (5NOT), CypA_lig60 (5NOU), CypA_lig61 (5NOV), CypA_lig89
(5NOW), CypA_lig97 (5NOX), CypA_lig98 (5NOY), CypA_lig99 (5NOZ). Fragments that bind to CypA based on X-ray crystallography data. Table 2 Summary of structural data for ligand 98. Protein residues or water molecules that are involved in H-bonding with 3 are colour coded separately. The distances between hydrogen bond donors and acceptors are given in Angstrom. 34 Table 2 Ligand 98 Technique X-ray MD (ΔGº bind ) -3.7 ± 0.4 kcal mol -1
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